TR201903287T4 - Hibrit/kimerik hücrelerin oluşturulmasına yönelik yöntemler ve bunların kullanımları. - Google Patents

Hibrit/kimerik hücrelerin oluşturulmasına yönelik yöntemler ve bunların kullanımları. Download PDF

Info

Publication number
TR201903287T4
TR201903287T4 TR2019/03287T TR201903287T TR201903287T4 TR 201903287 T4 TR201903287 T4 TR 201903287T4 TR 2019/03287 T TR2019/03287 T TR 2019/03287T TR 201903287 T TR201903287 T TR 201903287T TR 201903287 T4 TR201903287 T4 TR 201903287T4
Authority
TR
Turkey
Prior art keywords
cells
methods
generating hybrid
chimeric cells
hybrid cells
Prior art date
Application number
TR2019/03287T
Other languages
English (en)
Inventor
Kaseko Galina
L Mahaworasilpa Tohsak
Original Assignee
Bts Res International Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2009902652A external-priority patent/AU2009902652A0/en
Application filed by Bts Res International Pty Ltd filed Critical Bts Res International Pty Ltd
Publication of TR201903287T4 publication Critical patent/TR201903287T4/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C12N5/163—Animal cells one of the fusion partners being a B or a T lymphocyte
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C12N5/166—Animal cells resulting from interspecies fusion
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Mevcut buluş, hibrit hücreler ve hibrit hücrelerin üretimine yönelik yöntemler ile ilgilidir. Belirgin olarak, buluş, en az iki hücrenin farklı soylardan türetildiği en az üç hücrenin hibridizasyonundan üretilen hibrit hücreler ile ilgilidir. Buluş ayrıca, tanısal, profilaktik, terapötik ve/veya araştırma uygulamalarının bir aralığında kullanışlı proteinlerin ekspresyonuna yönelik hibrit hücrelerin kullanımı ile ilgilidir.
TR2019/03287T 2009-06-10 2010-06-10 Hibrit/kimerik hücrelerin oluşturulmasına yönelik yöntemler ve bunların kullanımları. TR201903287T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU2009902652A AU2009902652A0 (en) 2009-06-10 Methods of generating hybrid/chimeric cells, and uses thereof

Publications (1)

Publication Number Publication Date
TR201903287T4 true TR201903287T4 (tr) 2019-04-22

Family

ID=43308314

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2019/03287T TR201903287T4 (tr) 2009-06-10 2010-06-10 Hibrit/kimerik hücrelerin oluşturulmasına yönelik yöntemler ve bunların kullanımları.

Country Status (17)

Country Link
US (1) US8778677B2 (tr)
EP (1) EP2440653B1 (tr)
JP (1) JP5870026B2 (tr)
KR (1) KR101681480B1 (tr)
CN (3) CN107012125B (tr)
AU (1) AU2010258093B2 (tr)
CA (1) CA2764446C (tr)
DK (1) DK2440653T3 (tr)
ES (1) ES2714704T3 (tr)
IL (1) IL216842A (tr)
MY (1) MY155287A (tr)
PL (1) PL2440653T4 (tr)
RU (1) RU2536978C2 (tr)
SG (1) SG176302A1 (tr)
TR (1) TR201903287T4 (tr)
WO (1) WO2010141989A1 (tr)
ZA (1) ZA201200167B (tr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2010258094B2 (en) 2009-06-10 2013-09-05 Stephen Sanig Research Institute Ltd. Methods of generating cells exhibiting phenotypic plasticity
WO2013162330A1 (ko) * 2012-04-27 2013-10-31 이화여자대학교 산학협력단 키메라 중간엽 줄기세포군, 그의 제조방법 및 편도줄기세포를 이용하여 부갑상선 호르몬을 생산하는 방법
WO2016144642A1 (en) * 2015-03-06 2016-09-15 Chromologic Llc Genetically engineered host cells for malaria research
US20180250336A1 (en) * 2015-08-31 2018-09-06 The Trustees Of The University Of Pennsylvania Compositions and methods of enhancing anti-tumor response using hybrid neutrophils
WO2020251537A1 (en) * 2019-06-10 2020-12-17 CHO Plus Inc. Cell lines for high level production of protein-based pharmaceuticals

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5001065A (en) * 1987-05-27 1991-03-19 Cetus Corporation Human cell line and triomas, antibodies, and transformants derived therefrom
JPH02186982A (ja) * 1989-01-11 1990-07-23 Snow Brand Milk Prod Co Ltd ヒトＩｇＡの分泌能を有するヒト‐ヒトハイブリド‐マ
US6197582B1 (en) * 1998-03-18 2001-03-06 The Trustees Of Columbia University In The City Of New York Development of human monoclonal antibodies and uses thereof
US6136599A (en) * 1998-12-10 2000-10-24 Bayer Corporation Human hybrid host cell for mammalian gene expression
US20050170506A1 (en) * 2002-01-16 2005-08-04 Primegen Biotech Llc Therapeutic reprogramming, hybrid stem cells and maturation
US20050090004A1 (en) * 2003-01-16 2005-04-28 Sayre Chauncey B. Stem cell maturation for all tissue lines
US20060084167A1 (en) 2004-10-16 2006-04-20 Cohenford Menashi A Formation of Hybrid Cells by Fusion of Lineage Committed Cells with Stem Cells
US20100260675A1 (en) * 2004-12-09 2010-10-14 Chong Huang Oxytocin Receptor Antagonists and Their Use for the Treatment of Pulmonary Related Diseases
CN101365720A (zh) * 2005-08-26 2009-02-11 哥伦比亚大学 完全人杂交瘤融合配偶体细胞系
US20070266448A1 (en) * 2006-05-11 2007-11-15 Alexander Lifke Method for the production of antibodies
AU2010258094B2 (en) 2009-06-10 2013-09-05 Stephen Sanig Research Institute Ltd. Methods of generating cells exhibiting phenotypic plasticity

Also Published As

Publication number Publication date
JP5870026B2 (ja) 2016-02-24
DK2440653T3 (en) 2019-03-18
CA2764446C (en) 2018-08-21
CN107012125A (zh) 2017-08-04
US20120088272A1 (en) 2012-04-12
US8778677B2 (en) 2014-07-15
CN107012125B (zh) 2021-03-02
EP2440653B1 (en) 2018-12-05
ES2714704T3 (es) 2019-05-29
RU2536978C2 (ru) 2014-12-27
JP2012529270A (ja) 2012-11-22
SG176302A1 (en) 2012-01-30
EP2440653A1 (en) 2012-04-18
EP2440653A4 (en) 2014-01-29
PL2440653T4 (pl) 2019-07-31
MY155287A (en) 2015-09-30
IL216842A0 (en) 2012-02-29
CN102612556A (zh) 2012-07-25
AU2010258093B2 (en) 2013-08-22
RU2011152955A (ru) 2013-07-20
CA2764446A1 (en) 2010-12-16
WO2010141989A1 (en) 2010-12-16
CN107012126A (zh) 2017-08-04
IL216842A (en) 2017-01-31
PL2440653T3 (pl) 2019-05-31
KR20120058497A (ko) 2012-06-07
AU2010258093A1 (en) 2012-02-02
ZA201200167B (en) 2013-02-27
KR101681480B1 (ko) 2016-12-01

Similar Documents

Publication Publication Date Title
CY1121742T1 (el) Αντισωματα s100a4 και θεραπευτικες χρησεις αυτων
CY1120413T1 (el) Ειδικα εξανθρωπισμενα αντισωματα στην πρωτοϊνιδιακη μορφη του βητα-αμυλοειδους πεπτιδιου
TR201903981T4 (tr) Kanser tedavisi için bileşikler.
MX2021015971A (es) Construcciones de anticuerpos de adn y metodo para utilizarlas.
IN2014MN02635A (tr)
NZ623113A (en) Combined use of gdf traps and erythropoietin receptor activators to increase red blood cell levels
MX2020003168A (es) Pirimidinas modificadas en la posicion 5 y su uso.
MX2013004761A (es) Nuevas moleculas de union al receptor del factor de crecimiento epidermico (egfr) e inmunoconjugados de estas.
EP2331136A4 (en) FRIZZLED-BINDING SUBSTANCES AND ITS USES
BR112013027500A2 (pt) liberação controlada de imunossupressores de nanotransportadores sintéticos
NZ718280A (en) Antibodies against claudin 18.2 useful in cancer diagnosis
MX2012007710A (es) Alfa-amilasas.
MX2014003979A (es) Nucleosidos, nucleotidos, y acidos nucleicos modificados, y usos de los mismos.
MY173839A (en) Cd37-binding molecules and immunoconjugates thereof
EA201491418A1 (ru) Рекомбинантные микроорганизмы и способы их применения
BR112013009083A2 (pt) anticorpos humanos de oncostatin m e métodos de uso
TR201903287T4 (tr) Hibrit/kimerik hücrelerin oluşturulmasına yönelik yöntemler ve bunların kullanımları.
IN2015MN00436A (tr)
AU2011217848A8 (en) Integrin aVB8 neutralizing antibody
MX337203B (es) Novedosas moleculas inhbidoras de jnk.
UY34380A (es) ?determinación de polimorfismos de nucleótido simple útiles para predecir la respuesta clínica al acetato de glatirámero?.
BR112016013845A2 (pt) Métodos de perfilagem de epítopos de células t, produção de composições de células t e tratamento de doenças
TR201909721T4 (tr) 1700-2200 MPa çekme direncine sahip martensitli çelikler.
MX2014005651A (es) Composiciones de poliolefinas autoemulsionantes.
TR201909574T4 (tr) Hi̇droksi̇eti̇l ni̇şasta türevleri̇ni̇n üreti̇lmesi̇ne yöneli̇k yöntem.